Blood Cancer United, a nonprofit organization, is making headlines by purchasing the remaining supplies of Luvelta, an investigational cancer drug that has been discontinued.
This decision marks a significant step to ensure that patients who may benefit from the drug still have access to it, despite its discontinuation.
The move highlights the ongoing challenges in the availability of experimental treatments and the role nonprofits can play in addressing patient needs.
Updates
Update at 13:22 UTC on 2026-06-12
STAT reported The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta.
Sources: STAT